o NoneEntity Type
0001643301
Makkanotti Group Corp.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Cure Pharmaceutical Holding Corp.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Cure Pharmaceutical Holding Corp. 
Street Address 1Street Address 2
 1620 BEACON PLACE 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 OXNARD CALIFORNIA 93033 805-824-0410 



3. Related Persons
Last NameFirst NameMiddle Name
DavidsonRobert
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
BellJohn
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ChungLauren
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
GoldinAnya
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
HeldJosh
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
King-ShawRuben
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SalkindGene
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
YuanWilliam
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
DuitchNancy
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RedardMike
Street Address 1Street Address 2
1620 Beacon Place
CityState/Province/CountryZIP/Postal Code
OxnardCALIFORNIA93033
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-10-30 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities x Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Axiom Capital Management, Inc. 265801
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 350 Fifth Avenue, Suite 5420  
City State/Province/CountryZIP/Postal Code
 New York NEW YORK 10118
State(s) of Solicitation o All States o Foreign/Non-US
 CALIFORNIA
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 11500000 USD o Indefinite
Total Amount Sold $ 11500000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 For further explanation, please see the Current Report on Form 8-K filed by the Issuer on November 2, 2020.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 306000 USD x Estimate
 
Clarification of Response (if Necessary)
 Placement agent fee. This amount may increase up to an additional $480,000 upon achievement of certain milestones.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Cure Pharmaceutical (PK) (USOTC:CURR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Cure Pharmaceutical (PK).
Cure Pharmaceutical (PK) (USOTC:CURR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Cure Pharmaceutical (PK).

Noticias sobre Cure Pharmaceutical Holding Corp. CURR

Real-Time news about Cure Pharmaceutical Holding Corporation (PK) (OTCMarkets): 0 recent articles

Más de Cure Pharmaceutical Holding Corp. Artículos de Noticias

Su Consulta Reciente

Delayed Upgrade Clock